Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Weim Hsiang

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Scientific Reports|October 4, 2019
Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative RadiotherapyCheng-Hsiang Lo, Wen-Yen Huang, Chih-Weim Hsiang, et al.
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Journal of Hepatocellular Carcinoma|November 12, 2021
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular CarcinomaChih-Weim Hsiang, Wen-Yen Huang, Jen-Fu Yang, et al.
Yonsei Medical Journal|February 17, 2015
Clinical features and computed tomography characteristics of non-Klebsiella pneumoniae liver abscesses in elderly (>65 years) and nonelderly patientsChih-Weim Hsiang, Chang-Hsien Liu, Hsiu-Lung Fan, et al.
The Canadian Journal of Cardiology|January 10, 2022
Detection of Left Ventricular Systolic Dysfunction Using an Artificial Intelligence-Enabled Chest X-RayChih-Weim Hsiang, Chin Lin, Wen-Cheng Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2020
Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Hsin-Lun Lee, Chih-Weim Hsiang, et al.
Journal of Translational Medicine|October 14, 2024
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trialsHsin-Tien Ho, Yu-Lueng Shih, Tien-Yu Huang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Scientific Reports|October 4, 2019
Prognostic Significance of Apparent Diffusion Coefficient in Hepatocellular Carcinoma Patients treated with Stereotactic Ablative RadiotherapyCheng-Hsiang Lo, Wen-Yen Huang, Chih-Weim Hsiang, et al.
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Journal of Hepatocellular Carcinoma|November 12, 2021
Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular CarcinomaChih-Weim Hsiang, Wen-Yen Huang, Jen-Fu Yang, et al.
Yonsei Medical Journal|February 17, 2015
Clinical features and computed tomography characteristics of non-Klebsiella pneumoniae liver abscesses in elderly (>65 years) and nonelderly patientsChih-Weim Hsiang, Chang-Hsien Liu, Hsiu-Lung Fan, et al.
The Canadian Journal of Cardiology|January 10, 2022
Detection of Left Ventricular Systolic Dysfunction Using an Artificial Intelligence-Enabled Chest X-RayChih-Weim Hsiang, Chin Lin, Wen-Cheng Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2020
Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Hsin-Lun Lee, Chih-Weim Hsiang, et al.
Journal of Translational Medicine|October 14, 2024
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trialsHsin-Tien Ho, Yu-Lueng Shih, Tien-Yu Huang, et al.
Pageof 1